Interim Consolidated Balance Sheets (USD $) In Thousands	Sep. 30, 2011	Dec. 31, 2010
Current assets:
Cash and cash equivalents	$ 6,174	$ 5,947
Prepaid expense	82	38
Other current assets	15	8
Total assets	6,271	5,993
Current liabilities:
Accounts payable	414	272
Accrued liabilities	62	195
Derivative liability	9,465	10,450
Total liabilities	9,941	10,917
Commitments (see Note 8)
Stockholders' deficiency:
Common stock, no par value; unlimited shares authorized; 25,158 shares issued and outstanding (2010-20,461)	65,952	64,929
Additional paid-in capital	38,021	37,717
Deficit accumulated during development stage	(108,886)	(108,813)
Accumulated other comprehensive income	1,243	1,243
Total stockholders' deficiency	(3,670)	(4,924)
Total liabilities and stockholders' deficiency	$ 6,271	$ 5,993

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682